| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | United States | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wang Zhaoyin | 14 |
| #2 | Sun Yongkui | 14 |
| #3 | Zhou Gang | 14 |
| #4 | Quan Weiguo | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2021079013A1 | Heterobicyclic Carboxylic Acids and Salts Thereof | |
| CN111936138A | Heterobicyclic compounds as EP4 receptor antagonists | |
| US2020352906A1 | Heterobicyclic Carboxylic Acids for Treating Cancer or Inflammatory Diseases |